Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ivosidenib (AG-120)
ivosidenib (AG-120)
Agios scores its second new drug approval, ivosidenib heads to the AML market
Endpoints
Fri, 07/20/18 - 11:52 am
Agios Pharmaceuticals
ivosidenib (AG-120)
AML
acute myeloid leukemia